Literature DB >> 17031150

Molecular-phylogenetic analyses of human gastrointestinal microbiota.

D N Frank1, N R Pace.   

Abstract

Molecular-phylogenetic methods have revolutionized the analysis of complex microbial communities. Polymerase chain reaction amplification and phylogenetic analysis of small-subunit ribosomal RNA gene sequences allow microbes to be identified objectively, even in the absence of cultivation. Furthermore, the sequence information obtained by these means can be used to design sequence-based tools for identifying, tracking, and diagnosing the presence of microbes in complex samples. In this article, we summarize this approach and review its application to the study of the human gastrointestinal microbiota. Although just beginning, molecular-phylogenetic surveys of human gut microbes have revealed that most microbes identified in the gastrointestinal tract represent novel, previously undescribed species. A full description of the microbial constituents of the human gut will set the groundwork for interpreting how the gastrointestinal microbiota influence the health of the host.

Entities:  

Year:  2001        PMID: 17031150     DOI: 10.1097/00001574-200101000-00010

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  9 in total

1.  Culture-independent molecular analysis of microbial constituents of the healthy human outer ear.

Authors:  Daniel N Frank; George B Spiegelman; William Davis; Eileen Wagner; Eric Lyons; Norman R Pace
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

2.  Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon.

Authors:  Petra Louis; Sylvia H Duncan; Sheila I McCrae; Jacqueline Millar; Michelle S Jackson; Harry J Flint
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

3.  Identification of a bacterium that specifically catalyzes the reductive dechlorination of polychlorinated biphenyls with doubly flanked chlorines.

Authors:  Qingzhong Wu; Joy E M Watts; Kevin R Sowers; Harold D May
Journal:  Appl Environ Microbiol       Date:  2002-02       Impact factor: 4.792

Review 4.  Gut microbes, diet, and cancer.

Authors:  Meredith A J Hullar; Andrea N Burnett-Hartman; Johanna W Lampe
Journal:  Cancer Treat Res       Date:  2014

Review 5.  Genetic and environmental risk factors for rheumatoid arthritis.

Authors:  Kevin D Deane; M Kristen Demoruelle; Lindsay B Kelmenson; Kristine A Kuhn; Jill M Norris; V Michael Holers
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-09-18       Impact factor: 4.098

6.  Culture-independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota.

Authors:  Andrew B Dalby; Daniel N Frank; Allison L St Amand; Alison M Bendele; Norman R Pace
Journal:  Appl Environ Microbiol       Date:  2006-10       Impact factor: 4.792

7.  Characteristic male urine microbiomes associate with asymptomatic sexually transmitted infection.

Authors:  David E Nelson; Barbara Van Der Pol; Qunfeng Dong; Kashi V Revanna; Baochang Fan; Shraddha Easwaran; Erica Sodergren; George M Weinstock; Lixia Diao; J Dennis Fortenberry
Journal:  PLoS One       Date:  2010-11-24       Impact factor: 3.240

8.  High‑throughput sequencing analyses of oral microbial diversity in healthy people and patients with dental caries and periodontal disease.

Authors:  Tingtao Chen; Yan Shi; Xiaolei Wang; Xin Wang; Fanjing Meng; Shaoguo Yang; Jian Yang; Hongbo Xin
Journal:  Mol Med Rep       Date:  2017-05-17       Impact factor: 2.952

9.  Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study.

Authors:  Astrid-Jane Williams; Ramesh Paramsothy; Nan Wu; Simon Ghaly; Steven Leach; Sudarshan Paramsothy; Crispin Corte; Claire O'Brien; Catherine Burke; Gabrielle Wark; Dorit Samocha-Bonet; Kelly Lambert; Golo Ahlenstiel; Valerie Wasinger; Shoma Dutt; Paul Pavli; Michael Grimm; Daniel Lemberg; Susan Connor; Rupert Leong; Georgina Hold
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.